NO922456L - Bcrf1-proteiner som inhibitorer av interferon-gamma - Google Patents

Bcrf1-proteiner som inhibitorer av interferon-gamma

Info

Publication number: NO922456L
Authority: NO; Norway
Prior art keywords: inhibitors; interferon gamma; bcrf1; proteins; bcrf1 proteins
Prior art date: 1989-12-20

Application number

NO92922456A

Other languages

English (en)

Other versions

NO922456D0 (no

NO305703B1 (no

Inventor

Kevin W Moore

Robert A Kastelein

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-20

Filing date

1992-06-19

Publication date

1992-06-19

1992-06-19 Application filed by Schering Corp filed Critical Schering Corp

1992-06-19 Publication of NO922456L publication Critical patent/NO922456L/no

1992-06-19 Publication of NO922456D0 publication Critical patent/NO922456D0/no

1999-07-12 Publication of NO305703B1 publication Critical patent/NO305703B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO922456A 1989-12-20 1992-06-19 FremgangsmÕte for produksjon av et BCRF1-protein, som hemmer syntesen av interferon-<gamma> NO305703B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US45393189A	1989-12-20	1989-12-20
PCT/US1990/007288 WO1991009127A1 (en)	1989-12-20	1990-12-18	BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)

Publications (3)

Publication Number	Publication Date
NO922456L true NO922456L (no)	1992-06-19
NO922456D0 NO922456D0 (no)	1992-06-19
NO305703B1 NO305703B1 (no)	1999-07-12

Family

ID=23802631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO922456A NO305703B1 (no)	1989-12-20	1992-06-19	FremgangsmÕte for produksjon av et BCRF1-protein, som hemmer syntesen av interferon-<gamma>

Country Status (27)

Country	Link
US (2)	US5627155A (no)
EP (1)	EP0506836B1 (no)
JP (1)	JP2648236B2 (no)
KR (1)	KR960015199B1 (no)
CN (1)	CN1057012C (no)
AT (1)	ATE112317T1 (no)
AU (1)	AU7899694A (no)
CA (1)	CA2071907C (no)
CZ (1)	CZ283049B6 (no)
DE (1)	DE69013011T2 (no)
DK (1)	DK0506836T3 (no)
ES (1)	ES2064082T3 (no)
FI (1)	FI104883B (no)
HK (1)	HK185396A (no)
HU (1)	HU215909B (no)
IE (1)	IE72203B1 (no)
IL (1)	IL96715A0 (no)
MX (1)	MX9203409A (no)
MY (1)	MY107449A (no)
NO (1)	NO305703B1 (no)
NZ (1)	NZ236512A (no)
OA (1)	OA09703A (no)
PH (1)	PH31669A (no)
PT (1)	PT96231B (no)
SK (1)	SK279830B6 (no)
WO (1)	WO1991009127A1 (no)
ZA (1)	ZA9010188B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL94878A (en) *	1989-06-28	2003-01-12	Schering Corp	Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
CA2070416A1 (en) *	1989-10-23	1991-04-24	Richard Ingram	Polypeptide inhibitors of gamma interferon
KR100207766B1 (ko) *	1991-01-16	1999-07-15	둘락 노먼 씨.	신생물 질환 치료용 인터루킨-10 조성물
US6106823A (en)	1991-01-16	2000-08-22	Schering Corporation	Treatment of neoplastic disease with interleukin-10
AU678137B2 (en) *	1991-08-06	1997-05-22	Schering Corporation	Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
US5833976A (en) *	1991-08-06	1998-11-10	Schering Corporation	Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
US6008327A (en) *	1992-03-13	1999-12-28	Akzo Nobel, N.V.	Peptides and nucleic acid sequences related to the Epstein Barr virus
DE69334191T2 (de) *	1992-03-13	2008-11-27	bioMérieux B.V.	Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmente
WO1993018783A1 (en) *	1992-03-20	1993-09-30	Schering Corporation	Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
EP0726315B1 (en) *	1993-07-23	2001-10-17	Hans Prof. Dr. Wolf	Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
CA2298681C (en) *	1997-08-08	2008-07-08	Newbiotics, Inc.	Methods and compositions for overcoming resistance to biologic and chemotherapy
WO2013078378A1 (en)	2011-11-23	2013-05-30	Amgen Inc.	Methods of treatment using an antibody against interferon gamma
WO2022016509A1 (zh) *	2020-07-24	2022-01-27	阎忠扬	一种用以筛选药物的方法，以及该药物用于治疗牛皮癣的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3583564D1 (de) *	1984-08-23	1991-08-29	Hans Joachim Wolf	Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US5256768A (en) *	1985-12-13	1993-10-26	The Johns Hopkins University	Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics

1990
- 1990-12-18 PH PH41744A patent/PH31669A/en unknown
- 1990-12-18 KR KR1019920701474A patent/KR960015199B1/ko not_active IP Right Cessation
- 1990-12-18 CA CA002071907A patent/CA2071907C/en not_active Expired - Fee Related
- 1990-12-18 EP EP91902258A patent/EP0506836B1/en not_active Expired - Lifetime
- 1990-12-18 PT PT96231A patent/PT96231B/pt not_active IP Right Cessation
- 1990-12-18 HU HU9202075A patent/HU215909B/hu not_active IP Right Cessation
- 1990-12-18 SK SK6351-90A patent/SK279830B6/sk unknown
- 1990-12-18 WO PCT/US1990/007288 patent/WO1991009127A1/en active IP Right Grant
- 1990-12-18 AT AT91902258T patent/ATE112317T1/de not_active IP Right Cessation
- 1990-12-18 CZ CS906351A patent/CZ283049B6/cs not_active IP Right Cessation
- 1990-12-18 NZ NZ236512A patent/NZ236512A/en unknown
- 1990-12-18 ZA ZA9010188A patent/ZA9010188B/xx unknown
- 1990-12-18 IL IL96715A patent/IL96715A0/xx unknown
- 1990-12-18 DE DE69013011T patent/DE69013011T2/de not_active Expired - Fee Related
- 1990-12-18 ES ES91902258T patent/ES2064082T3/es not_active Expired - Lifetime
- 1990-12-18 DK DK91902258.2T patent/DK0506836T3/da active
- 1990-12-18 JP JP3502513A patent/JP2648236B2/ja not_active Expired - Fee Related
- 1990-12-18 MX MX9203409A patent/MX9203409A/es unknown
- 1990-12-19 IE IE458890A patent/IE72203B1/en not_active IP Right Cessation
- 1990-12-19 MY MYPI90002207A patent/MY107449A/en unknown
- 1990-12-19 CN CN90110079A patent/CN1057012C/zh not_active Expired - Fee Related
1992
- 1992-06-16 FI FI922770A patent/FI104883B/fi active
- 1992-06-19 NO NO922456A patent/NO305703B1/no not_active IP Right Cessation
- 1992-06-19 OA OA60232A patent/OA09703A/en unknown
1994
- 1994-11-23 AU AU78996/94A patent/AU7899694A/en not_active Abandoned
1995
- 1995-05-26 US US08/450,749 patent/US5627155A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,950 patent/US5736390A/en not_active Expired - Lifetime
1996
- 1996-01-03 HK HK185396A patent/HK185396A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9202075D0 (en)	1992-10-28
IE72203B1 (en)	1997-04-09
DK0506836T3 (da)	1994-11-28
IE904588A1 (en)	1991-07-03
CZ283049B6 (cs)	1997-12-17
CN1057012C (zh)	2000-10-04
NZ236512A (en)	1997-07-27
ZA9010188B (en)	1991-08-28
SK635190A3 (en)	1999-04-13
MX9203409A (es)	1992-07-01
CA2071907A1 (en)	1991-06-21
FI922770A (fi)	1992-06-16
ES2064082T3 (es)	1995-01-16
FI922770A0 (fi)	1992-06-16
JP2648236B2 (ja)	1997-08-27
SK279830B6 (sk)	1999-04-13
NO922456D0 (no)	1992-06-19
DE69013011T2 (de)	1995-02-23
DE69013011D1 (de)	1994-11-03
FI104883B (fi)	2000-04-28
JPH05503846A (ja)	1993-06-24
EP0506836A1 (en)	1992-10-07
US5736390A (en)	1998-04-07
EP0506836B1 (en)	1994-09-28
CN1052608A (zh)	1991-07-03
IL96715A0 (en)	1991-09-16
AU7899694A (en)	1995-02-09
WO1991009127A1 (en)	1991-06-27
HU215909B (hu)	1999-03-29
AU7063691A (en)	1991-07-18
NO305703B1 (no)	1999-07-12
CA2071907C (en)	2000-08-08
PT96231B (pt)	1998-09-30
PH31669A (en)	1999-01-18
CZ635190A3 (en)	1997-09-17
PT96231A (pt)	1991-09-30
HUT65369A (en)	1994-05-02
KR960015199B1 (ko)	1996-11-01
MY107449A (en)	1995-12-31
HK185396A (en)	1996-10-11
OA09703A (en)	1993-08-30
AU652732B2 (en)	1994-09-08
ATE112317T1 (de)	1994-10-15
US5627155A (en)	1997-05-06

Publication	Publication Date	Title
EP0335901A4 (en)	1990-11-28	Methods and compositions for the treatment of non-ige-mediated diseases
HK1040493A1 (en)	2002-06-14	Use of mammalian cytokine synthesis inhibitory factor in manufacturing a medicament.
ES8602768A1 (es)	1985-11-16	Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
ES2156852T3 (es)	2001-08-01	Citoquina mamifera, il-11.
FI935585A0 (fi)	1993-12-13	Pyrrolopyrimidiner
NO922456D0 (no)	1992-06-19	Bcrf1-proteiner som inhibitorer av interferon-gamma
DE69130679D1 (de)	1999-02-04	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
FI922428A0 (fi)	1992-05-27	Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE45675T1 (de)	1989-09-15	Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
NO874391L (no)	1988-04-25	Nye gjaerekspresjonsvektorer for ifn-omega samt fremgangsmaate for fremstilling og anvendelse derav.

Legal Events

Date	Code	Title	Description
2003-07-28	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN JUNE 2003